Healthcare provider profile · identity verified

Christa W Lehman, ARNP

Nurse Practitioner · JACKSONVILLE, FL · NPI 1124534268

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	196	61
Amlodipine Besylate	Amlodipine Besylate	145	49
Lisinopril	Lisinopril	123	41
Levothyroxine Sodium	Levothyroxine Sodium	122	38
Losartan Potassium	Losartan Potassium	93	34
Rosuvastatin Calcium	Rosuvastatin Calcium	92	32
Metformin Hcl	Metformin Hcl	86	33
Gabapentin	Gabapentin	85	28
Omeprazole	Omeprazole	85	28
Fluticasone Propionate	Fluticasone Propionate	69	34
Alprazolam	Alprazolam	64	14
Metoprolol Succinate	Metoprolol Succinate	56	15
Zolpidem Tartrate	Zolpidem Tartrate	53	suppressed
Alendronate Sodium	Alendronate Sodium	48	14
Ezetimibe	Ezetimibe	46	16
Famotidine	Famotidine	41	17
Trazodone Hcl	Trazodone Hcl	41	14
Hydrochlorothiazide	Hydrochlorothiazide	39	18
Simvastatin	Simvastatin	39	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	12
Ozempic	Semaglutide	36	suppressed
Prednisone	Prednisone	36	27
Sertraline Hcl	Sertraline Hcl	33	12
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Furosemide	Furosemide	28	13
Albuterol Sulfate Hfa	Albuterol Sulfate	27	17
Pantoprazole Sodium	Pantoprazole Sodium	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Azithromycin	Azithromycin	26	23
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	15
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Methocarbamol	Methocarbamol	23	12
Montelukast Sodium	Montelukast Sodium	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	14
Carvedilol	Carvedilol	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Naproxen	Naproxen	19	11
Bupropion Xl	Bupropion Hcl	18	suppressed
Cephalexin	Cephalexin	18	14
Farxiga	Dapagliflozin Propanediol	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Meloxicam	Meloxicam	17	suppressed
Atenolol	Atenolol	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Invokana	Canagliflozin	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Diazepam	Diazepam	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Estradiol	Estradiol	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error